dc.creatorSzmulewicz, Alejandro G.
dc.creatorFerraris, Augusto
dc.creatorRodriguez, Agustín
dc.creatorCampos Cervera, Lucía
dc.creatorLopez Gonzalez, Macarena
dc.creatorMan, Federico
dc.creatorAngriman, Federico
dc.creatorMartino, Diego Javier
dc.date.accessioned2020-03-12T20:58:27Z
dc.date.accessioned2022-10-15T12:51:15Z
dc.date.available2020-03-12T20:58:27Z
dc.date.available2022-10-15T12:51:15Z
dc.date.created2020-03-12T20:58:27Z
dc.date.issued2018-07
dc.identifierSzmulewicz, Alejandro G.; Ferraris, Augusto; Rodriguez, Agustín; Campos Cervera, Lucía; Lopez Gonzalez, Macarena; et al.; All-cause mortality in older adults with affective disorders and dementia under treatment with antipsychotic drugs: A matched-cohort study; Elsevier Ireland; Psychiatry Research; 265; 7-2018; 82-86
dc.identifier0165-1781
dc.identifierhttp://hdl.handle.net/11336/99400
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4388120
dc.description.abstractWe aimed to compare the mortality risk between patients with affective disorders and dementia under treatment with antipsychotics. To do this, a matched-cohort study based on an electronic database of a tertiary teaching hospital in Argentina was performed. Antipsychotic exposure was defined as any antipsychotic drug initiated by the patient. Primary outcome was defined as all-cause mortality during the 5-year follow-up period. To estimate the association between baseline diagnosis (affective disorders vs. dementia) and all-cause mortality, we used a multivariate generalized linear model with robust standard errors. Of 1008 eligible patients, 114 age-matched pairs were included in the present study. The primary event occurred in 23 patients (20%) and 17 patients (15%) in the dementia and affective disorder group respectively. In the adjusted model, the risk of all cause mortality for the affective disorders group was 0.92 times the risk for the dementia group (95%CI, 0.54–1.59, p = 0.77). In conclusion, older patients with affective disorders starting antipsychotic treatment presented with a similar risk of all-cause mortality during the 5-year follow-up when compared to older patients with dementia who were also initiating either typical or atypical antipsychotic medications. Closer medical attention to older patients with mental conditions under antipsychotic treatment remains warranted.
dc.languageeng
dc.publisherElsevier Ireland
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0165178117315792
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.psychres.2018.04.034
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectANTIPSYCHOTIC AGENTS
dc.subjectCOHORT STUDY
dc.subjectMENTAL HEALTH
dc.subjectOLDER ADULTS
dc.subjectPHARMACOEPIDEMIOLOGY
dc.titleAll-cause mortality in older adults with affective disorders and dementia under treatment with antipsychotic drugs: A matched-cohort study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución